As a complementary approach to classical antibody-mediated checkpoint blockade, administration of a short-acting peptide (Compound 8) that inhibits PD-1/PD-L1 signaling also provided a significant survival benefit in mice with secondary C. albicans sepsis after CLP (31). The gene discussed is PDCD1; the disease is Sepsis.